Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
Go back to Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance| Abbott Laboratories (NYSE: ABT) | Delayed: 98.39 -4.06 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.45 | 52 Week High | $46.38 | |||
| Open | $101.31 | 52 Week Low | $36.00 | |||
| Day High | $106.35 | P/E | 65.59 | |||
| Day Low | $97.67 | EPS | $1.50 | |||
| Volume | 13,776,503 | |||||



